Economy/Business News Alert: Panel overwhelmingly backs previously rejected anti-obesity pill Qnexa

	Wednesday, February 22, 2012 5:04:24 PM ECONOMY/BUSINESS NEWS ALERT Panel overwhelmingly backs previously rejected anti-obesity pill Qnexa A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns. The FDA panel of outside physicians voted 20-2 in favor of the weight loss drug Qnexa, setting the stage for a potential comeback for a drug that has been plagued by side effects since it was first submitted to the agency in 2010. Read more at: http://www.washingtonpost.com/business/fda-panel-overwhelmingly-backs-previously-rejected-anti-obesity-pill-qnexa/2012/02/22/gIQAyuZrTR_story.html Or visit PostBusiness.com. SEND TO A FRIEND UNSUBSCRIBE E-MAIL CENTER GET HELP Washington Post Digital E-mail Customer Care 1150 15th Street NW Washington, D.C. 20071 ©2011 The Washington Post Privacy Policy